<DOC>
	<DOCNO>NCT02235584</DOCNO>
	<brief_summary>In study examine whether induce insulin resistance dexamethasone healthy volunteer lead decrease insulinotropic effect hormone GLP-1 GIP .</brief_summary>
	<brief_title>Insulinotropic Effect GLP-1 GIP After Dexamethasone</brief_title>
	<detailed_description>In study go examine insulinotropic property GLP-1 GIP development insulin resistance and/or glucose intolerance.The insulinotropic property GLP-1 GIP greatly reduce type 2 diabetes . Since development type 2 diabetes precede insulin resistance glucose intolerance want examine insulinotropic property GLP-1 GIP early stage type 2 diabetes . To , want induce insulin resistance and/or glucose intolerance . This achieve 5 day treatment dexamethasone . Subjects study 4 different day randomize order , oral glucose tolerance test ( OGTT ) glucose clamp + infusion GLP-1 , GIP NaCl immediately 5 day treatment dexamethasone , 2mg bid . On day 1 , 2 3 5 day dexamethasone , 2mg dexamethasone give afternoon test ensure unchanged insulin resistance</detailed_description>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Caucasians 20 45 year age Normal glucose tolerance assess WHO criteria First degree relative least 1 second degree relative type 2 diabetes Normal haemoglobin Informed consent Liver disease ( ALAT/ASAT &gt; 2 time normal value ) Kidney disease ( Screatinin &gt; 130uM and/or albuminuria ) Heart disease ( NYHA II , III IV ) Treatment medicine pause Pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Incretin hormone</keyword>
	<keyword>GLP-1</keyword>
	<keyword>GIP</keyword>
	<keyword>Dexamethasone</keyword>
</DOC>